Abstract
Beta cell replacement by islet transplantation is a promising treatment for patients with type 1 diabetes mellitus. However, shortage of donor tissue demands for an alternative source to generate beta cells. Cells from the pancreatic duct compartment are an attractive alternative source for beta cell replacement therapy.
Author information
Authors and Affiliations
Corresponding author
Additional information
1 Department of Nephrology, LUMC, Albinusdreef 2, Leiden, The Netherlands, 2 Hubrecht Institute, Uppsalalaan 8, Utrecht, The Netherlands. E-mail: J.R.A.Balak@lumc.nl
About this article
Cite this article
Balak, J., Spijker, H., Loomans, C. et al. PS2 - 3. The effect of INGAP, FGF7 and a GLP-1R agonist on the differentiation of primary human duct cells towards beta cells. NED. TIJDSCHR. DIABET. 11, 137–138 (2013). https://doi.org/10.1007/s12467-013-0071-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12467-013-0071-1